Myriad Genetics' Q4 Revenues Rise 24 Percent; Ramp up of European Operations Continues | GenomeWeb

NEW YORK (GenomeWeb News) – Myriad Genetics reported after the close of the market Tuesday that revenues for its fiscal fourth quarter rose 24 percent year over year, beating the consensus Wall Street estimate.

The company also reported that revenues for full-year fiscal 2012 increased 23 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.